Enabling the Digital Revolution of Health

The society for in silico medicine

VPH is an international community driving the adoption of in silico medicine by connecting scientists, industry, clinicians, patients, healthcare providers, regulators, and policymakers for a better and more efficient healthcare.

  • 25

    Countries involved

  • 40+

    Institutions involved

  • 1000+

    Members

  • VPH2026 brings together 650 experts in Milan to advance in silico medicine

    Read more

Collaborations

  •  

     

  •  

     

  •  

     

News & Events

  • Policy News

    European Parliament advances MDR/IVDR revision: critical implications for In Silico & Digital Health Technologies

    As the European Union moves forward with revising Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR), the European Parliament’s Committee on Environment, Public Health and Food Safety (SANT) is taking a central role in recalibrating the MedTech regulatory landscape.

    Discover more
  • Policy News

    EMA launches Pre-Submission Interactions pilot to improve MAA readiness

    The European Medicines Agency (EMA) has initiated a voluntary pilot testing a revised model for Pre-Submission Interactions (PSI) ahead of initial Marketing Authorisation Applications (MAAs).

    Discover more
  • News

    From Credibility to Trust

    On 3 September 2026, during the VPH Conference in Milan, VPH hosted a plenary roundtable "From Credibility to Trust".

    Discover more